TickerFacts.

Atea Pharmaceuticals, Inc. (AVIR): Share Repurchases

Annual figures by period end, from SEC filings.

$25.52M
Year ended 2025-12-31
2024-12-31: $02025-12-31: $25.52M$25.52M
2024-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$25.52Mn/a2026-03-05, From 2025-01-01
2024-12-31$0n/a2026-03-05, From 2024-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Atea Pharmaceuticals, Inc. (AVIR)2025-12-31$25.52Mn/a
Omeros Corp (OMER)2025-12-31$0-100.0%
Keros Therapeutics, Inc. (KROS)2025-12-31$375.00Mn/a
Zentalis Pharmaceuticals, Inc. (ZNTL)2025-12-31$9.98Mn/a
Zymeworks Inc. (ZYME)2025-12-31$41.70M+38.7%
Zevra Therapeutics, Inc. (ZVRA)2024-12-31$0-100.0%
Nektar Therapeutics (NKTR)2025-12-31$0-100.0%
Tonix Pharmaceuticals Holding Corp. (TNXP)2025-12-31$13.76Mn/a
Anaptysbio, Inc (ANAB)2025-12-31$68.63Mn/m

Compare AVIR, OMER, KROS, ZNTL side by side · Screen every company in Pharmaceutical Preparations ↗